; (2) recognize the importance of reducing malaria prevalence and deaths to improve overall child and maternal health in all endemic regions, especially in sub-Saharan Africa; (3) commend the recent progress made toward reducing global malaria morbidity, mortality, and prevalence, particularly through the efforts of the President’s Malaria Initiative and the Global Fund to Fight AIDS, Tuberculosis and Malaria; (4) commend the efforts and achievements in preventing and treating malaria by endemic countries through the national malaria control programs of such countries; (5) welcome ongoing public-private partnerships to research and develop more effective and affordable tools for malaria prevention, diagnosis, treatment, and vaccination; (6) recognize the goals, priorities, and authorities to combat malaria set forth in the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 ( Public Law 110–293 ; 122 Stat. 2918); (7) support efforts to reduce malaria case incidence and malaria mortality rates by at least 90 percent by 2030; (8) support continued leadership by the United States in bilateral, multilateral, and private sector efforts to combat malaria and to work with developing countries to create long-term strategies to increase ownership over malaria programs; and (9) encourage other members of the international community to sustain and increase their support for, and financial contributions to, efforts to combat malaria worldwide. 3. Reporting requirement Not later than 180 days after the date of the enactment of this Act, the Administrator of the United States Agency for International Development shall submit to Congress a report on the cumulative progress toward 90 percent malaria reduction by 2030, including by providing incidence and mortality rates of malaria.